These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 25444607)

  • 1. Higher homocysteine associated with thinner cortical gray matter in 803 participants from the Alzheimer's Disease Neuroimaging Initiative.
    Madsen SK; Rajagopalan P; Joshi SH; Toga AW; Thompson PM;
    Neurobiol Aging; 2015 Jan; 36 Suppl 1():S203-10. PubMed ID: 25444607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping ventricular expansion onto cortical gray matter in older adults.
    Madsen SK; Gutman BA; Joshi SH; Toga AW; Jack CR; Weiner MW; Thompson PM;
    Neurobiol Aging; 2015 Jan; 36 Suppl 1():S32-41. PubMed ID: 25311280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homocysteine effects on brain volumes mapped in 732 elderly individuals.
    Rajagopalan P; Hua X; Toga AW; Jack CR; Weiner MW; Thompson PM
    Neuroreport; 2011 Jun; 22(8):391-5. PubMed ID: 21512418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventing Alzheimer's disease-related gray matter atrophy by B-vitamin treatment.
    Douaud G; Refsum H; de Jager CA; Jacoby R; Nichols TE; Smith SM; Smith AD
    Proc Natl Acad Sci U S A; 2013 Jun; 110(23):9523-8. PubMed ID: 23690582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gray matter atrophy in patients with mild cognitive impairment/Alzheimer's disease over the course of developing delusions.
    Fischer CE; Ting WK; Millikin CP; Ismail Z; Schweizer TA;
    Int J Geriatr Psychiatry; 2016 Jan; 31(1):76-82. PubMed ID: 25821062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of lifestyle and vascular risk factors with Alzheimer's brain biomarker changes during middle age: a 3-year longitudinal study in the broader New York City area.
    Walters MJ; Sterling J; Quinn C; Ganzer C; Osorio RS; Andrews RD; Matthews DC; Vallabhajosula S; de Leon MJ; Isaacson RS; Mosconi L
    BMJ Open; 2018 Nov; 8(11):e023664. PubMed ID: 30478117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-subject gray matter networks predict future cortical atrophy in preclinical Alzheimer's disease.
    Dicks E; van der Flier WM; Scheltens P; Barkhof F; Tijms BM;
    Neurobiol Aging; 2020 Oct; 94():71-80. PubMed ID: 32585492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homocysteine and Cerebral Atrophy: The Epidemiology of Dementia in Singapore Study.
    Tan B; Venketasubramanian N; Vrooman H; Cheng CY; Wong TY; Ikram MK; Chen C; Hilal S
    J Alzheimers Dis; 2018; 62(2):877-885. PubMed ID: 29480177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of gray matter microstructural changes in Alzheimer's disease continuum using fiber orientation.
    Lee P; Kim HR; Jeong Y;
    BMC Neurol; 2020 Oct; 20(1):362. PubMed ID: 33008321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gray matter volume and estimated brain age gap are not linked with sleep-disordered breathing.
    Mohajer B; Abbasi N; Mohammadi E; Khazaie H; Osorio RS; Rosenzweig I; Eickhoff CR; Zarei M; Tahmasian M; Eickhoff SB;
    Hum Brain Mapp; 2020 Aug; 41(11):3034-3044. PubMed ID: 32239749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frontobasal gray matter loss is associated with the TREM2 p.R47H variant.
    Luis EO; Ortega-Cubero S; Lamet I; Razquin C; Cruchaga C; Benitez BA; Lorenzo E; Irigoyen J; ; Pastor MA; Pastor P
    Neurobiol Aging; 2014 Dec; 35(12):2681-2690. PubMed ID: 25027412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated Homocysteine Level and Brain Atrophy Changes as Markers to Screen the Alzheimer Disease: Case Series.
    Sah RP; Vidya CS; Pereira P; Jayaram S; Yadav AK; Sujatha P
    Ann Geriatr Med Res; 2024 Mar; 28(1):116-120. PubMed ID: 38105011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
    Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
    Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Divergent regional patterns of cerebral hypoperfusion and gray matter atrophy in mild cognitive impairment patients.
    Wirth M; Pichet Binette A; Brunecker P; Köbe T; Witte AV; Flöel A
    J Cereb Blood Flow Metab; 2017 Mar; 37(3):814-824. PubMed ID: 27037094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
    Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E genotype modulates effects of vitamin B12 and homocysteine on grey matter volume in Alzheimer's disease.
    Lee YM; Ha JK; Park JM; Lee BD; Moon E; Chung YI; Kim JH; Kim HJ; Mun CW; Kim TH; Kim YH
    Psychogeriatrics; 2016 Jan; 16(1):3-11. PubMed ID: 25919635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.
    Benedet AL; Leuzy A; Pascoal TA; Ashton NJ; Mathotaarachchi S; Savard M; Therriault J; Kang MS; Chamoun M; Schöll M; Zimmer ER; Gauthier S; Labbe A; Zetterberg H; Rosa-Neto P; Blennow K;
    Brain; 2020 Dec; 143(12):3793-3804. PubMed ID: 33210117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated cortical structural marker for Alzheimer's disease.
    Ming J; Harms MP; Morris JC; Beg MF; Wang L
    Neurobiol Aging; 2015 Jan; 36 Suppl 1():S53-9. PubMed ID: 25444604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of regional gray matter atrophy, white matter alteration, and glucose metabolism as a predictor of the conversion to Alzheimer's disease in mild cognitive impairment.
    Sohn BK; Yi D; Seo EH; Choe YM; Kim JW; Kim SG; Choi HJ; Byun MS; Jhoo JH; Woo JI; Lee DY
    J Korean Med Sci; 2015 Jun; 30(6):779-87. PubMed ID: 26028932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral changes and disrupted gray matter cortical networks in asymptomatic older adults at risk for Alzheimer's disease.
    Cantero JL; Atienza M; Sanchez-Juan P; Rodriguez-Rodriguez E; Vazquez-Higuera JL; Pozueta A; Gonzalez-Suarez A; Vilaplana E; Pegueroles J; Montal V; Blesa R; Alcolea D; Lleo A; Fortea J
    Neurobiol Aging; 2018 Apr; 64():58-67. PubMed ID: 29331877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.